Latest Regulatory News


ECHA: BPC Concludes on Union Authorisations

In late June 2019 the BP Committee (BPC) adopted four opinions, including one on the non-approval of the active substance (DBNPA – PT4) on ED properties and three (2 x PT4; 1 x PT18) on Union Authorisation (UA).

DBNPA is not approved for product type 4 unless one of the following BPR derogations can be applied:

  1. The risk of exposure to the environment, human and animal health is proven to be negligible; or
  2. There is evidence that the active substance is essential to prevent or control a serious danger to the environment, human or animal health; or
  3. The non-approval is shown to have a negative impact on society compared to the risks arising from the use of the substance.

The positive opinion supporting UA for PT18 is one application concerning a biocidal product family based on permethrin and S-Methoprene.

The next BPC meeting will be held in October 2019.

 

Latest Regulatory News

Jun-2020

News > Vet Medicine

Regulatory Flexibility for Veterinary Medicines during COVID-19 Pandemic

The European Commission, EMA and the Coordination Group for Mutual Recognition and Decentralised Procedure (Veterinary) have issued guidance on adaptations to the regulatory framework to...

Read More

May-2020

Biocides > News

Non-Compliant Hazardous Mixtures

44 % of hazardous mixtures have been found to be not compliant with classification and labelling obligations. An EU-wide Forum enforcement project has found significant...

Read More

Contact

LKC Switzerland Ltd
Hauptstrasse 10
P.O. Box 167
4414 Füllinsdorf
Switzerland

Phone: +41 (0) 61 906 8500
Fax: +41 (0) 61 906 8509
LKC@lkc-ltd.com

Information

Registration Number: CHE-113.597.134

Upcoming Events

2007-2020 © Copyright LKC Switzerland Ltd

Sign Up for Newsletter

x